Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Pre-pilot Open-label Clinical Trial of Nabilone for Severe Behavioural Problems (Aggression) in Adults With Intellectual and Developmental Disabilities

NCT05273320 is registered in ClinicalTrials.gov with Hsiang-Yuan Lin as lead sponsor.

NCT NCT05273320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05273320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Pre-pilot Open-label Clinical Trial of Nabilone for Severe Behavioural Problems (Aggression) in Adults With Intellectual and Developmental Disabilities
Lead sponsor
Hsiang-Yuan Lin
Phase
Phase 1
Overall status
Completed
Start date
March 17, 2022
Completion date
August 14, 2025
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aggression, behavior problem, developmental disability, intellectual disability